Overview

Use of NovoSeven® in Active Variceal Bleeding

Status:
Completed

Trial end date:
2006-08-01

Target enrollment:

Participant gender:

Summary

This trial is conducted in Asia and Europe. The trial is planned to investigate the effectiveness and safety of NovoSeven® in patients with advanced cirrhosis and active variceal bleeding.

Phase:

Phase 2

Details

Lead Sponsor:

Novo Nordisk A/S